KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

by Pao, William, Wang, Theresa Y, Riely, Gregory J, Miller, Vincent A, Pan, Qiulu, Ladanyi, Marc, Zakowski, Maureen F, Heelan, Robert T, Kris, Mark G, Varmus, Harold E
Published 2005

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

by Pao, William, Miller, Vincent A, Politi, Katerina A, Riely, Gregory J, Somwar, Romel, Zakowski, Maureen F, Kris, Mark G, Varmus, Harold
Published 2005

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large cell carcinoma

by Rekhtman, Natasha, Tafe, Laura J., Chaft, Jamie E., Wang, Lu, Arcila, Maria E., Colanta, Agnes, Moreira, Andre L., Zakowski, Maureen F., Travis, William D., Sima, Camelia S., Kris, Mark G., Ladanyi, Marc
Published 2012

A Phase 2 Single Arm Trial of Cabozantinib in Patients with Advanced RET-Rearranged Lung Cancers

by Drilon, Alexander, Rekhtman, Natasha, Arcila, Maria, Wang, Lu, Ni, Andy, Albano, Melanie, Van Voorthuysen, Martine, Somwar, Romel, Smith, Roger S., Montecalvo, Joseph, Plodkowski, Andrew, Ginsberg, Michelle S., Riely, Gregory J., Rudin, Charles M., Ladanyi, Marc, Kris, Mark G.
Published 2016

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma

by Hutchinson, Katherine E., Johnson, Douglas B., Johnson, Adam S., Sanchez, Violeta, Kuba, Maria, Lu, Pengcheng, Chen, Xi, Kelley, Mark C., Wang, Qingguo, Zhao, Zhongming, Kris, Mark, Berger, Michael F., Sosman, Jeffrey A., Pao, William
Published 2015

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

by Li, Bob T., Lou, Emil, Hsu, Meier, Yu, Helena A., Naidoo, Jarushka, Zauderer, Marjorie G., Sima, Camelia, Johnson, Melissa L., Daras, Mariza, DeAngelis, Lisa M., Fleisher, Martin, Kris, Mark G., Azzoli, Christopher G.
Published 2016

Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4

by Marks, Jenifer L., McLellan, Michael D., Zakowski, Maureen F., Lash, Alex E., Kasai, Yumi, Broderick, Stephen, Sarkaria, Inderpal S., Pham, DuyKhanh, Singh, Bhuvanesh, Miner, Tracie L., Fewell, Ginger A., Fulton, Lucinda L., Mardis, Elaine R., Wilson, Richard K., Kris, Mark G., Rusch, Valerie W., Varmus, Harold, Pao, William
Published 2007